Subscribe
Guideline statin eligibility and coronary risk, cost-effectiveness of coronary risk thresholds, patiromer for hyperkalemia, managing polypharmacy, and more.

JAMA Editor’s Summary

Guideline statin eligibility and coronary risk, cost-effectiveness of coronary risk thresholds, patiromer for hyperkalemia, managing polypharmacy, and more.

Editor's Audio Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the July 14, 2015 issue
July 14, 2015
ADVERTISEMENT
Wise-Formerly Transferwise

Guideline statin eligibility and coronary risk, cost-effectiveness of coronary risk thresholds, patiromer for hyperkalemia, managing polypharmacy, and more.

Editor’s Audio Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the July 14, 2015 issue

ADVERTISEMENT
WP Engine Wordpress Hosting

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Proudly supported by:

cover
Making the World a Healthier Place with AI and Data Mary Claire Duch, President of W2O pure & Jonathan Woodring, EVP & GM of IPM.ai